Discovery of Novel 1,3,5‐trisubstituted‐2‐thioxo‐imidazole Derivatives as Potential Aromatase Inhibitors: Design, Synthesis, In Vitro Anti‐Breast Cancer Screening and Molecular Docking Studies

Documenti analoghi

• In vivo anticancer study of sodium 2‐[(4‐oxidobenzylidene)amino]‐6H‐1,3,4‐thiadiazine‐5‐olate against Ehrlich ascites carcinoma via targeting PI3K/mTOR pathway
  di: Youstina William Rizzk, et al.
  Pubblicazione: (2024)
• Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
  di: Shreetama Bandyopadhayaya, et al.
  Pubblicazione: (2025)
• Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
  di: Marwa I. Serag, et al.
  Pubblicazione: (2024)
• Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
  di: Ankit Kumar Singh, et al.
  Pubblicazione: (2025)
• Synthesis, Cytotoxic Activity, and Molecular Docking Study of New Thiazole‐Incorporated Indenopyridazine Derivatives as Potential Antiproliferative Drugs
  di: Alaa M. Alqahtani, et al.
  Pubblicazione: (2025)